시장보고서

상품코드

1558381

방사선 종양학 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 유형별, 용도별, 지역별

Radiation Oncology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography

발행일: 2024년 08월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 170 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 방사선 종양학 시장은 2023년 89억 2,444만 달러에서 성장하며, 2031년에는 236억 2,056만 달러에 달할 것으로 예측되고 있으며, 2023-2031년 13.0%의 CAGR을 기록할 전망입니다. 방사선 종양학 시장의 성장은 암 유병률 증가와 방사선 종양학 시장 개발을 지원하는 구상의 급증에 기인합니다. 방사선 종양학 시장 기업의 전략적 구상은 시장 성장 기회를 제공할 가능성이 높습니다. 방사선 종양학 시장 보고서는 시장을 주도하는 주요 요인을 강조하고 유명한 기업 시장 개척을 소개합니다.

방사선 치료 또는 방사선 치료는 방사선(보통 고출력 X선)을 사용하여 암세포를 죽이는 일반적인 암 치료법입니다. 방사선 치료는 단독으로 사용되기도 하고, 수술이나 화학요법과 같은 다른 치료와 병행하여 사용되기도 합니다. 방사선 종양 전문의는 방사선 치료를 전문으로 하는 의료 서비스 프로바이더입니다.

2023년 세계 방사선 종양학 시장에서 북미가 큰 비중을 차지할 것으로 예상됩니다. 북미 방사선종양학 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국에서는 모든 암 환자에게 방사선 치료가 광범위하게 시행되고 있으며, 방사선 종양 전문의에 대한 수요가 지속적으로 증가하고 있습니다. 의료 인프라가 발달한 만큼 방사선종양학과 의사의 수도 지속적으로 증가하고 있습니다. 미국임상종양학회(American Society of Clinical Oncology)에 따르면 전 세계 암 환자의 약 2/3가 치료의 일환으로 방사선 치료를 받고 있으며, 2022년에는 미국에서 연간 100만 명 이상의 암 환자가 방사선 치료를 받을 것으로 예상됩니다. 방사선 치료를 받을 것으로 예상됩니다. 정부와 의료 당국은 방사선 치료의 도입을 촉진하기 위해 여러 가지 구상을 취하고 있으며, 2020년 6월 미국 방사선종양학회(ASTRO)는 비전이성 자궁경부암에 대한 방사선 치료에 대한 새로운 임상 가이드라인을 발표했습니다. 새로운 가이드라인은 방사선 치료를 시행하기 위한 절차와 과정을 정확하게 시행하는 데 초점을 맞추었습니다. 캐나다 방사선종양학회(CARO)는 방사선종양학에 대한 구체적인 가이드라인을 제정했으며, Journal of Clinical Oncology에 게재된 연구에 따르면 온타리오주에서는 연간 약 35,000명의 환자가 방사선 치료를 받고 있습니다. 는 온타리오주 암 환자의 약 39%를 차지합니다. 캐나다의 인구 기반 단일 지불 암 시스템은 접근성, 진단의 질, 치료 결과 및 지원을 강화하기 위해 지속적으로 변화하고 있습니다. 이 시스템은 방사선 치료도 잘 배치되어 사람들이 이 치료를 충분히 받을 수 있도록 하고 있습니다. 그러나 이 치료법에 대한 접근성은 면밀한 모니터링이 필요합니다. 캐나다는 인구의 고령화와 기술 발전으로 인해 방사선 종양학 분야의 혁신, 연구 및 관행이 계속 변화할 것입니다. 암 발병률 증가, 정부의 구상, 기술 발전은 멕시코의 방사선 종양학 시장의 성장을 가속하는 몇 가지 요인입니다. 멕시코는 특히 폐암, 전립선암, 유방암 발병률이 높아 효과적인 치료를 위해 방사선 치료에 대한 수요가 증가하고 있습니다. 멕시코 정부는 해외 투자 및 국제적인 기업을 유치하기 위해 많은 노력을 기울이고 있습니다. 예를 들어 2018년 엘렉타는 멕시코 정부로부터 방사선 치료 시스템 납품 입찰을 받았습니다. 이러한 협력 관계는 예측 기간 중 멕시코 방사선 종양학 시장을 촉진할 것으로 예상됩니다.

방사선종양학 분야에서의 전략적 접근이 향후 시장 기회를 가져다 줄 것입니다.

방사선종양학은 암 치료에 있으며, 매우 큰 잠재력을 가지고 있습니다. 또한 제품 개발, 기술 혁신, 제품 출시, 제품 승인, 합병, 인수, 제휴 등 시장 기업의 끊임없는 방사선 치료의 진화가 시장 성장에 기여할 것으로 예상됩니다. 최근 이 시장에서 진행된 전략적 구상 중 일부는 다음과 같습니다.

2024년 5월, Elekta는 새로운 고화질 AI 강화 영상이 탑재된 CT 선형락인 Evo를 출시하여 표준 영상 유도 방사선 치료뿐만 아니라 오프라인 및 온라인 적응형 방사선 치료를 개선할 수 있는 새로운 CT 선형락인 Evo를 출시했습니다. 개선할 수 있습니다.

2024년 5월, 아이콘 그룹은 사이버나이프 호주(Cyberknife Australia)와 제휴하여 '사이버나이프' 시스템을 이용한 방사선종양학 치료를 제공하는 최대 6개의 방사선종양학 클리닉을 신설(합작투자 계획)할 예정입니다.

2024년 5월, GE헬스케어는 혁신적인 하드웨어 및 소프트웨어 솔루션을 갖춘 새로운 방사선 치료용 CT 솔루션인 레볼루션 RT를 출시했습니다.

2024년 4월, Aculay Incorporated는 ESTRO 2024에서 암 치료 경험을 개선하기 위해 설계된 하드웨어 및 소프트웨어의 진보를 전시했습니다. 최신 세대의 사이버나이프와 Radixact 플랫폼은 방사선 치료의 치유력을 확장하고 올해 회의의 초점인 치료 격차를 해소하는 데 필요한 기술을 의료진에게 제공합니다.

2023년 10월, CIVCO Radiotherapy와 Qfix는 새로운 브랜드 CQ Medical을 론칭했습니다. 이 회사는 임상의 및 기술 파트너와 현장의 심층적인 참여와 함께 암 치료 및 환자 결과 개선에 중점을 둘 것입니다.

2023년 9월, MVision AI는 효과적인 방사선 치료 컨투어링을 위한 최초의 종합적인 GBS(Guideline-Based Segmentation) 솔루션을 발표했습니다. Verify는 윤곽의 시각적 및 체적 비교를 가능하게 하여 병원이 유사점과 차이점을 쉽게 관찰할 수 있도록 도와주며, Guide Verify와 Contour를 함께 도입하면 방사선 치료 윤곽에 대한 모든 임상적 필요를 충족시킬 수 있습니다. 모든 임상적 니즈를 충족합니다.

따라서 방사선 종양학 시장에서 사업을 운영하는 시장 기업 사이에서 전략적 구상이 급증하고 있으며, 이는 시장 성장을 증폭시키고 방사선 종양학 시장에서 충분한 기회를 창출할 것으로 예상됩니다.

방사선종양학 시장 경쟁 구도 및 주요 발전

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide(Ion Beam Applications SA), Becton Dickinson &Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, Mallinckrodt Plc. 등이 방사선 종양학 시장에서 사업을 운영하는 주요 기업입니다.

미국 식품의약국, 미국 질병통제예방센터(CDC), 미국방사선종양학회 등은 방사선종양학 시장 보고서를 작성할 때 참고한 1차 및 2차 정보 중 하나입니다.

방사선 종양학 시장 - 주요 시장 역학
시장 성장 촉진요인
- 암의 유병률 증가
- 방사선 종양학의 발전을 지원하는 구상
시장 성장 억제요인
- 방사선 치료 기기의 고비용
시장 기회
- 방사선 종양학의 전략적 구상
향후 동향
- 방사선 종양학의 기술 진보
촉진요인과 억제요인의 영향

제6장 방사선 종양학 시장 : 세계 시장 분석

방사선 종양학 시장 매출, 2021-2031년

제7장 방사선 종양학 시장 분석 : 유형별

외부 빔 방사선 요법
내부 빔 방사선 요법

제8장 방사선 종양학 시장 분석 : 용도별

유방암
전립선암
폐암
두경부암
자궁경부암
기타

제9장 방사선 종양학 시장 : 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제10장 방사선 종양학 시장 : 업계 상황

방사선 종양학 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략
- 성장 전략

제11장 기업 개요

Varian Medical Systems Inc
Elekta AB
Accuray Incorporated
IBA Worldwide(Ion Beam Applications SA)
Becton Dickinson and Co
Perspective Therapeutics Inc
Nordion
Mevion Medical Systems
NTP RADIOISOTOPES
Mallinckrodt Plc
Provision Healthcare
Panacea Medical Technologies Pvt. Ltd
Curium

제12장 부록

KSA 24.10.10

According to our new research study on "Radiation Oncology Market Forecast to 2031 -Global Analysis - by Type, Application, and Geography," the market is anticipated to grow from US$ 8,924.44 million in 2023 and is projected to reach US$ 23,620.56 million by 2031; it is expected to register a CAGR of 13.0% during 2023-2031. The radiation oncology market growth is attributed to the increasing prevalence of cancer and surging initiatives to support developments in radiation oncology. Strategic initiatives by radiation oncology market players are likely to offer opportunities for market growth. The radiation oncology market report emphasizes the key factors driving the market and showcases the developments of prominent players.

Radiation therapy or radiotherapy is a common cancer treatment that uses radiation (usually high-powered X-rays) to kill cancer cells. Radiation therapy may be used independently or alongside other treatments, like surgery or chemotherapy. Radiation oncologists are healthcare providers who specialize in radiation therapy.

North America accounted for a major share of the global radiation oncology market in 2023. The North America radiation oncology market is segmented into the US, Canada, and Mexico. Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2022, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy. The Canadian Association of Radiation Oncology (CARO) has established specific guidelines about radiation oncology. A study published in the Japanese Journal of Clinical Oncology reports that nearly 35,000 patients in Ontario receive radiation therapy annually, accounting for ~39% of cancer patients in the province. Canada's population-based, single-payer cancer system constantly changes to enhance access, diagnosis quality, treatment outcomes, and support. It has also positioned radiotherapy well, ensuring that people have sufficient access to this treatment. Nonetheless, access to the treatment needs close monitoring. Canada plans to continue to innovate, conduct research, and change the practice of radiation oncology as its population ages and technology advances. Rising cancer incidence, government initiatives, and technology improvements are a few factors driving growth of the radiation oncology market in Mexico. The country specifically records high incidences of lung, prostate, and breast cancer, resulting in an elevated demand for radiation therapy for effective treatment. The government of Mexico focuses on attracting significant foreign investments and international players. For instance, in 2018, Elekta received a tender from the government of Mexico to deliver radiation therapy systems. Such collaborations are estimated to boost the Mexico radiation oncology market during the forecast period.

Strategic Initiatives in Radiation Oncology to Provide Market Opportunities in Future

Radiation oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.

In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.

In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.

In October 2023, CIVCO Radiotherapy and Qfix launched a new brand CQ Medical. The company focuses on the improvement of cancer care and patient outcome along with deep engagement in the field with clinicians and technology partners.

In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Radiation Oncology Market: Competitive Landscape and Key Developments

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc. are among the key companies operating in the radiation oncology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Radiation Oncology are among the primary and secondary sources referred to while preparing the radiation oncology market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Radiation Oncology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Radiation Oncology Market - Key Market Dynamics

5.1 Radiation Oncology Market - Key Market Dynamics
5.2 Market Drivers:
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Initiatives to Support Developments in Radiation Oncology
5.3 Market Restraints
- 5.3.1 High Cost of Radiotherapy Equipment
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives in Radiation Oncology
5.5 Future Trends
- 5.5.1 Technological Advancement in Radiation Oncology
5.6 Impact of Drivers and Restraints:

6. Radiation Oncology Market - Global Market Analysis

6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. Radiation Oncology Market Analysis - by Types

7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Radiation Oncology Market Analysis - by Application

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
- 8.4.1 Overview
- 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
- 8.5.1 Overview
- 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. Radiation Oncology Market - Geographical Analysis

9.1 North America
- 9.1.1 North America Radiation Oncology Market Overview
- 9.1.2 North America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  - 9.1.2.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
  - 9.1.2.2 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
  - 9.1.2.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
  - 9.1.2.4 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
- 9.1.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.1.3.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
    - 9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
  - 9.1.3.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
    - 9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
  - 9.1.3.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
    - 9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
9.2 Europe
- 9.2.1 Europe Radiation Oncology Market Overview
- 9.2.2 Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  - 9.2.2.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
  - 9.2.2.2 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
  - 9.2.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
  - 9.2.2.4 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
- 9.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.2.3.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
  - 9.2.3.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
  - 9.2.3.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
  - 9.2.3.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
  - 9.2.3.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
  - 9.2.3.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
    - 9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
9.3 Asia Pacific
- 9.3.1 Asia Pacific Radiation Oncology Market Overview
- 9.3.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  - 9.3.2.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
  - 9.3.2.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
  - 9.3.2.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
  - 9.3.2.4 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
- 9.3.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.3.3.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
  - 9.3.3.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
  - 9.3.3.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
  - 9.3.3.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
  - 9.3.3.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
    - 9.3.3.5.5 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
    - 9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9.4 Middle East and Africa
- 9.4.1 Middle East and Africa Radiation Oncology Market Overview
- 9.4.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  - 9.4.2.1 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
  - 9.4.2.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
  - 9.4.2.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
  - 9.4.2.4 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
- 9.4.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.4.3.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
    - 9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
  - 9.4.3.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
    - 9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
  - 9.4.3.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
    - 9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
  - 9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
    - 9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
9.5 South and Central America
- 9.5.1 South and Central America Radiation Oncology Market Overview
- 9.5.2 South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  - 9.5.2.1 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
  - 9.5.2.2 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
  - 9.5.2.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
  - 9.5.2.4 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
- 9.5.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.1 Brazil: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
    - 9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
  - 9.5.3.2 Argentina: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
    - 9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
  - 9.5.3.3 Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
    - 9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Varian Medical Systems Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview (Siemens Healthineers AG)
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Elekta AB
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Accuray Incorporated
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Becton Dickinson and Co
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Nordion
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Mevion Medical Systems
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 NTP RADIOISOTOPES
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Mallinckrodt Plc
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Provision Healthcare
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 Panacea Medical Technologies Pvt. Ltd
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 Curium
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms